Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.23B
Close$
$7.72
38% downside
Current Fair Value
38% downsideOvervalued by 38% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.23 Billion |
|---|---|
| Enterprise Value | $4.75 Billion |
| Dividend Yield | $0.25 (1.81%) |
| Earnings per Share | $0.12 |
| Beta | 0.47 |
| Outstanding Shares | 379,331,587 |
Return
| Return on Equity | 3.73% |
|---|---|
| Return on Assets | 2.73% |
| Return on Invested Capital | 2.99% |
Valuation & Multiples
| P/E Ratio | 37.93 |
|---|---|
| PEG | 4.34 |
| Price to Sales | 1.78 |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | 1.68 |
| Enterprise Value to EBIT | 40.02 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shandong Jincheng Pharmaceutical Group Co., Ltd
3,515 employees
CEO: Jiaquan Li Shandong Jincheng Pharmaceutical Group Co., Ltd., together with its affiliated companies, focuses on the global research, development, manufacturing, and distribution of Cephalosporin intermediates. The Group's extensive product line inc...